Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Letter]

Ozlem Yilmaz, Gulistan Bahat Department of Internal Medicine, Division of Geriatrics, Istanbul University School of Medicine, Istanbul 34093, TurkeyCorrespondence: Ozlem YilmazDepartment of Internal Medicine, Division of Geriatrics, Istanbul University School of Medicine, Topkapı Mahallesi, Turgut &...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yilmaz O, Bahat G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	sarc-f validation study sarcopenia screening tool Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/6493e5198dbd49879c861e1beca3283a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6493e5198dbd49879c861e1beca3283a
record_format	dspace
spelling	oai:doaj.org-article:6493e5198dbd49879c861e1beca3283a2021-12-02T10:23:03ZImportant Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Letter]1178-1998https://doaj.org/article/6493e5198dbd49879c861e1beca3283a2020-06-01T00:00:00Zhttps://www.dovepress.com/important-points-to-consider-during-practical-application-and-in-the-v-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Ozlem Yilmaz, Gulistan Bahat Department of Internal Medicine, Division of Geriatrics, Istanbul University School of Medicine, Istanbul 34093, TurkeyCorrespondence: Ozlem YilmazDepartment of Internal Medicine, Division of Geriatrics, Istanbul University School of Medicine, Topkapı Mahallesi, Turgut Özal Caddesi̇ No: 118, Istanbul 34093, TurkeyTel +90 212 414 20 00- 31478, 33090Fax +90 212 414 22 48Email dr.ozlemyilmaz@hotmail.com We have read the study of Zasadzka et al entitled “Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia” with great interest.1 In this paper, the authors reported their study on Polish validation of the SARC-F questionnaire and reported it as a reliable tool for the assessment of sarcopenia in older adults.    As authors noted, SARC-F has originally been developed in English. As it stands as one of the best tools to evaluate sarcopenia in every day practice, considering the variety of languages across Europe, the European Union Geriatric Medicine Society (EuGMS) special interest group on sarcopenia  coordinated a study to promote the cross-cultural adaptation, validation and consequent use of SARC-F. We published a methodological report paper to explain the details of the final consensus methodology.2 In accordance with this aim, we are glad to see that Polish validation of SARC-F tool has been reported by the authors. However, we see that there are some problematic points in the article which should be clarified to help readers.   View the original paper by Zasadzka and colleaguesYilmaz OBahat GDove Medical Pressarticlesarc-fvalidation studysarcopenia screening toolGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 15, Pp 877-878 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	sarc-f validation study sarcopenia screening tool Geriatrics RC952-954.6
spellingShingle	sarc-f validation study sarcopenia screening tool Geriatrics RC952-954.6 Yilmaz O Bahat G Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Letter]
description	Ozlem Yilmaz, Gulistan Bahat Department of Internal Medicine, Division of Geriatrics, Istanbul University School of Medicine, Istanbul 34093, TurkeyCorrespondence: Ozlem YilmazDepartment of Internal Medicine, Division of Geriatrics, Istanbul University School of Medicine, Topkapı Mahallesi, Turgut Özal Caddesi̇ No: 118, Istanbul 34093, TurkeyTel +90 212 414 20 00- 31478, 33090Fax +90 212 414 22 48Email dr.ozlemyilmaz@hotmail.com We have read the study of Zasadzka et al entitled “Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia” with great interest.1 In this paper, the authors reported their study on Polish validation of the SARC-F questionnaire and reported it as a reliable tool for the assessment of sarcopenia in older adults.    As authors noted, SARC-F has originally been developed in English. As it stands as one of the best tools to evaluate sarcopenia in every day practice, considering the variety of languages across Europe, the European Union Geriatric Medicine Society (EuGMS) special interest group on sarcopenia  coordinated a study to promote the cross-cultural adaptation, validation and consequent use of SARC-F. We published a methodological report paper to explain the details of the final consensus methodology.2 In accordance with this aim, we are glad to see that Polish validation of SARC-F tool has been reported by the authors. However, we see that there are some problematic points in the article which should be clarified to help readers.   View the original paper by Zasadzka and colleagues
format	article
author	Yilmaz O Bahat G
author_facet	Yilmaz O Bahat G
author_sort	Yilmaz O
title	Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Letter]
title_short	Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Letter]
title_full	Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Letter]
title_fullStr	Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Letter]
title_full_unstemmed	Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Letter]
title_sort	important points to consider during practical application and in the validation studies of sarc-f tool to screen sarcopenia [letter]
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/6493e5198dbd49879c861e1beca3283a
work_keys_str_mv	AT yilmazo importantpointstoconsiderduringpracticalapplicationandinthevalidationstudiesofsarcftooltoscreensarcopenialetter AT bahatg importantpointstoconsiderduringpracticalapplicationandinthevalidationstudiesofsarcftooltoscreensarcopenialetter
_version_	1718397344193445888

Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Letter]

Ejemplares similares